222 related articles for article (PubMed ID: 26802083)
1. Consecutive Measurements by Faecal Immunochemical Test in Quiescent Ulcerative Colitis Patients Can Detect Clinical Relapse.
Hiraoka S; Kato J; Nakarai A; Takashima S; Inokuchi T; Takei D; Sugihara Y; Takahara M; Harada K; Okada H
J Crohns Colitis; 2016 Jun; 10(6):687-94. PubMed ID: 26802083
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of Faecal Immunochemical Test to Predict Endoscopic and Histological Healing in Ulcerative Colitis: A Prospective Study Based on Validated Histological Scores.
Shi HY; Chan FKL; Chan AWH; Higashimori A; Kyaw M; Ching JYL; Luk AKC; Wong SH; Wu JCY; Sung JJY; Ng SC
J Crohns Colitis; 2017 Sep; 11(9):1071-1077. PubMed ID: 28881876
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Mucosal Healing in Ulcerative Colitis by Fecal Calprotectin Vs. Fecal Immunochemical Test.
Takashima S; Kato J; Hiraoka S; Nakarai A; Takei D; Inokuchi T; Sugihara Y; Takahara M; Harada K; Okada H; Tanaka T; Yamamoto K
Am J Gastroenterol; 2015 Jun; 110(6):873-80. PubMed ID: 25823769
[TBL] [Abstract][Full Text] [Related]
4. Assessment of disease activity by fecal immunochemical test in ulcerative colitis.
Ryu DG; Kim HW; Park SB; Kang DH; Choi CW; Kim SJ; Nam HS
World J Gastroenterol; 2016 Dec; 22(48):10617-10624. PubMed ID: 28082814
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous Measurements of Faecal Calprotectin and the Faecal Immunochemical Test in Quiescent Ulcerative Colitis Patients Can Stratify Risk of Relapse.
Nakarai A; Hiraoka S; Takahashi S; Inaba T; Higashi R; Mizuno M; Takashima S; Inokuchi T; Sugihara Y; Takahara M; Harada K; Kato J; Okada H
J Crohns Colitis; 2018 Jan; 12(1):71-76. PubMed ID: 28961792
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of mucosal healing of ulcerative colitis by a quantitative fecal immunochemical test.
Nakarai A; Kato J; Hiraoka S; Kuriyama M; Akita M; Hirakawa T; Okada H; Yamamoto K
Am J Gastroenterol; 2013 Jan; 108(1):83-9. PubMed ID: 23007005
[TBL] [Abstract][Full Text] [Related]
7. Ulcerative colitis patients in clinical remission demonstrate correlations between fecal immunochemical test results, mucosal healing, and risk of relapse.
Nakarai A; Kato J; Hiraoka S; Takashima S; Takei D; Inokuchi T; Sugihara Y; Takahara M; Harada K; Okada H
World J Gastroenterol; 2016 Jun; 22(21):5079-87. PubMed ID: 27275100
[TBL] [Abstract][Full Text] [Related]
8. Fecal calprotectin is more accurate than fecal immunochemical test for predicting mucosal healing in quiescent ulcerative colitis: a prospective multicenter study.
Kim ES; Lee HS; Kim SK; Kim EY; Jang BI; Kim KO; Yang CH; Lee YJ;
Scand J Gastroenterol; 2020 Feb; 55(2):163-168. PubMed ID: 31984815
[No Abstract] [Full Text] [Related]
9. Improved monitoring of inflammatory activity in patients with ulcerative colitis by combination of faecal tests for haemoglobin and calprotectin.
Karling P; Lundgren D; Eklöf V; Palmqvist R; Hultdin J
Scand J Clin Lab Invest; 2019 Sep; 79(5):341-346. PubMed ID: 31164011
[TBL] [Abstract][Full Text] [Related]
10. Faecal Lactoferrin, Calprotectin, PMN-elastase, CRP, and White Blood Cell Count as Indicators for Mucosal Healing and Clinical Course of Disease in Patients with Mild to Moderate Ulcerative Colitis: Post Hoc Analysis of a Prospective Clinical Trial.
Langhorst J; Boone J; Lauche R; Rueffer A; Dobos G
J Crohns Colitis; 2016 Jul; 10(7):786-94. PubMed ID: 26874351
[TBL] [Abstract][Full Text] [Related]
11. Faecal calprotectin level for assessing endoscopic activity and predicting future clinical course in patients with moderately active ulcerative colitis undergoing granulomonocytapheresis: a prospective cohort study.
Shimoyama T; Yamamoto T; Umegae S; Matsumoto K
BMC Gastroenterol; 2018 Aug; 18(1):120. PubMed ID: 30068300
[TBL] [Abstract][Full Text] [Related]
12. Clinical application of faecal calprotectin in ulcerative colitis patients.
Scaioli E; Scagliarini M; Cardamone C; Liverani E; Ugolini G; Festi D; Bazzoli F; Belluzzi A
Eur J Gastroenterol Hepatol; 2015 Dec; 27(12):1418-24. PubMed ID: 26308711
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of advanced endoscopy and fecal calprotectin for prediction of relapse in ulcerative colitis: a prospective study.
Jauregui-Amezaga A; López-Cerón M; Aceituno M; Jimeno M; Rodríguez de Miguel C; Pinó-Donnay S; Zabalza M; Sans M; Ricart E; Ordás I; González-Suárez B; Cuatrecasas M; Llach J; Panés J; Pellise M
Inflamm Bowel Dis; 2014 Jul; 20(7):1187-93. PubMed ID: 24874457
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of ulcerative colitis differs between patients with complete and partial mucosal healing, which can be predicted from the platelet count.
Nakarai A; Kato J; Hiraoka S; Inokuchi T; Takei D; Moritou Y; Akita M; Takahashi S; Hori K; Harada K; Okada H; Yamamoto K
World J Gastroenterol; 2014 Dec; 20(48):18367-74. PubMed ID: 25561804
[TBL] [Abstract][Full Text] [Related]
15. Fecal calprotectin is a clinically relevant biomarker of mucosal healing in patients with quiescent ulcerative colitis.
Yamaguchi S; Takeuchi Y; Arai K; Fukuda K; Kuroki Y; Asonuma K; Takahashi H; Saruta M; Yoshida H
J Gastroenterol Hepatol; 2016 Jan; 31(1):93-8. PubMed ID: 26212346
[TBL] [Abstract][Full Text] [Related]
16. Fecal immunochemical test for predicting mucosal healing in ulcerative colitis patients: A systematic review and meta-analysis.
Dai C; Jiang M; Sun MJ; Cao Q
J Gastroenterol Hepatol; 2018 May; 33(5):990-997. PubMed ID: 29427297
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Risk of Relapse in Ulcerative Colitis According to the Degree of Mucosal Healing (Mayo 0 vs 1): A Longitudinal Cohort Study.
Barreiro-de Acosta M; Vallejo N; de la Iglesia D; Uribarri L; Bastón I; Ferreiro-Iglesias R; Lorenzo A; Domínguez-Muñoz JE
J Crohns Colitis; 2016 Jan; 10(1):13-9. PubMed ID: 26351390
[TBL] [Abstract][Full Text] [Related]
18. Effect of mucosal healing (Mayo 0) on clinical relapse in patients with ulcerative colitis in clinical remission.
Kim JH; Cheon JH; Park Y; Lee HJ; Park SJ; Kim TI; Kim WH
Scand J Gastroenterol; 2016 Sep; 51(9):1069-74. PubMed ID: 26895215
[TBL] [Abstract][Full Text] [Related]
19. Fecal Immunochemical Test and Fecal Calprotectin Results Show Different Profiles in Disease Monitoring for Ulcerative Colitis.
Hiraoka S; Inokuchi T; Nakarai A; Takashima S; Takei D; Sugihara Y; Takahara M; Harada K; Okada H; Kato J
Gut Liver; 2018 Mar; 12(2):142-148. PubMed ID: 28873508
[TBL] [Abstract][Full Text] [Related]
20. Low fecal calprotectin predicts sustained clinical remission in inflammatory bowel disease patients: a plea for deep remission.
Mooiweer E; Severs M; Schipper ME; Fidder HH; Siersema PD; Laheij RJ; Oldenburg B
J Crohns Colitis; 2015 Jan; 9(1):50-5. PubMed ID: 25518048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
